Recent years have seen heat shock protein 90 kDa (Hsp90) attract significant interest as a viable drug target, particularly for cancer. To date, designed inhibitors that target the ATPase domain demonstrate potent anti-proliferative effects, but have failed clinical trials due to high levels of associated toxicity. To circumvent this, the focus has shifted away from the ATPase domain. One option involves modulation of the protein through allosteric activation/inhibition. Here, we propose a novel approach: we use previously obtained information via residue perturbation scanning coupled with dynamic residue network analysis to identify allosteric drug targeting sites for inhibitor docking. We probe the open conformation of human Hsp90α for druggable sites that overlap with these allosteric control elements, and identify three putative natural compound allosteric modulators: Cephalostatin 17, 20(29)-Lupene-3β-isoferulate and 3'-Bromorubrolide F. We assess the allosteric potential of these ligands by examining their effect on the conformational dynamics of the protein. We find evidence for the selective allosteric activation and inhibition of Hsp90's conformational transition toward the closed state in response to ligand binding and shed valuable insight to further the understanding of allosteric drug design and Hsp90's complex allosteric mechanism of action.
Introduction
The 90 KDa heat shock protein (Hsp90) is a highly conserved molecular chaperone crucially involved in maintaining cellular homoeostasis in organisms from most kingdoms of life with the exception of archea 1 . In the cytosol, Hsp90's main biological function is the facilitation of folding, maturation, and trafficking of numerous client peptides both native and denatured [2] [3] [4] . Hsp90's diverse array of clientele implicate the chaperone in several associated biological functions and place it at the intersection of various fundamental cellular pathways, where it acts as a central hub in maintaining numerous protein interaction networks 1 .
Hsp90 exists as a homodimer (Figure 1-A) , and each protomer is comprised of three well characterized domains [5] [6] [7] : an N-terminal domain (NTD) which is responsible for ATPase activity and facilitating transient inter-protomer dimerization 8 ; a middle domain (M-domain) that provides a large surface area for cofactor and client binding and contributes to ATPase activation 9 ; a Cterminal domain (CTD) which serves as the primary site for inter-protomer dimerization 10, 11 . The NTD and M-domain are connected by a highly flexible charged linker that has been implicated in modulating chaperone function [12] [13] [14] [15] . Hsp90's molecular function critically hinges around its ability to bind and release client peptides via a complex nucleotide dependent conformational cycle (Figure 1-B) . In a nucleotide free state, the dimer becomes highly flexible and is capable of assuming multiple conformers with a higher affinity for an open "v-like" conformation in which the M-domains of each protomer are suitably exposed for client loading [16] [17] [18] . ATP binding triggers structural rearrangements in the NTD that promote dimerization at the N-terminal, stabilizing a closed catalytically active conformation 10, 19 . Transition to the closed ATPase active state is an inherently slow process recording time constants in the order of minutes 8, 20, 21 , possibly due to energetic barriers presented by structural intermediates that may be overcome through cofactor mediation [22] [23] [24] [25] . ATP hydrolysis and the subsequent release of ADP from the NTD initiate a conformational return to the native apo open state and client release.
The interaction of Hsp90 with several disease related peptides implicate the chaperone with the progression and development of several associated pathologies such as protein folding disorders, cancer, and neurological disease 5 . In recent years it has become increasingly clear that deregulation of Hsp90 may present an attractive treatment strategy for these diseases, elevating interest in human Hsp90 as a viable drug target particularly for the treatment of cancer [26] [27] [28] . To date, Hsp90 inhibitors have largely targeted the ATPase domain, demonstrating potent anti-proliferative effects; however, their progression through clinical trials has been severely limited due to high levels of toxicity associated with an induced heat shock response 26 . For this reason, recent research has shifted focus away from the NTD to targeting distant functional sites of the protein as alternative drug treatment strategies. The design and development of inhibitors that target the formation of specific Hsp90-cochaperone complexes, has led to the discovery of inhibitors such as Derrubone, Withaferin A , and Celastrol which block the Hsp90-Cdc37 complex 29 . Discovery of a secondary nucleotide binding site at the CTD led to the design and development of several CTD inhibitors including the coumarin based antibiotic Novobiocin that has been shown to allosterically destabilise the Hsp90 dimer by interfering with CTD dimerization leading to the dissociation of bound clients [30] [31] [32] . These CTD inhibitors of Hsp90 have a distinct advantage over the NTD ATPase inhibitors, in that they do not appear to induce secondary heat shock responses and thus incur lower levels of toxicity 29 .
Figure 1: Illustration of Hsp90α in the open conformation. (A)
The location of the different binding site residues are shaded: Site-1 helix [18] [19] (red), helix [21] [22] four-helix bundle (yellow) and Site-2 sub-pocket (blue). The NTD location of ATP and magnesium ions (spheres) are also shown. (B) Hsp90's nucleotide driven conformational cycle (Adopted from Penkler et al. 37 ). (C) Insetzoomed in view of docked compounds SANC309 red, SANC491 green, SANC518 blue, and Novobiocin magenta.
To date, biochemical and computational studies have demonstrated allosteric coupling between the NTD and CTD [33] [34] [35] [36] [37] suggesting nucleotide driven conformational restructuring may be influenced by allosteric events at the CTD. More specifically, computational studies based on the closed conformation of yeast Hsp90 have identified a putative allosteric binding site located at the Mdomain:CTD inter-protomer interface that is implicated in allosteric modulation of conformational dynamics 33, 35, 38 . Subsequent to this discovery, further studies have led to the development of several allosteric CTD ligands that appear to enhance ATPase activity up to six-fold by promoting conformational dynamics in favour of the ATPase active closed conformation 39, 40 . Furthermore, a recent biochemical study has provided evidence of Bisphenol A based CTD inhibitors of human Hsp90α that bind a site separate from the nucleotide binding site 41 and display anti-proliferative activity in tumour cell lines 42 . In a previous computational study, we used all-atom molecular dynamics (MD) simulations coupled with dynamic residue networks (DRN) and perturbation response scanning (PRS) to determine allosteric hotspots that may be implicated in modulating conformational dynamics in human Hsp90α 37 . Focusing on the open "v-like" conformation, we identified several residues located at the M-domain:CTD interface that form a central hub in the protein interaction network, and provided evidence that when externally perturbed by random force displacements these residues are capable of selecting global conformational displacements towards the ATPase active closed conformation 37 .
In the present study we propose that force perturbations at the aforementioned sites, may occur naturally through binding forces engendered by protein-protein and protein-ligand interactions; and that these allosteric hotspots may present a suitable allosteric drug target candidates. We probe two putative ligand binding sites that were identified by combined PRS and DRN analysis 37 , and supported by FTMap 43 screening at the CTD as potential allosteric drug targeting sites (Figure 1 Site-1 & Site-2). We found three South African Natural compounds (SANC) that dock to these sites: Cephalostatin 17 (SANC491) and 20(29)-Lupene-3β-isoferulate (SANC518) preferentially bound at Site-1 together with the known CTD inhibitor Novobiocin which was included for comparative control purposes; and 3'-Bromorubrolide F (SANC309) docked at Site-2. We utilized several allatom MD simulation based analysis techniques, to assess the allosteric potential of each site to modulate protein conformational dynamics in response to ligand interactions.
Results and Discussion

Identification of novel natural compounds that bind the CTD
The availability of putative small molecule binding sites at the CTD of the "v-like" open conformation of human Hsp90α 37 was assessed using FTMap 43 with an unbiased screen positioned over the M-domain:CTD region, resulting in two candidate binding sites overlapping with allosteric control elements and identified in our previous study via combined PRS and DRN analysis 37 (Figure S1). Site-1 is at the CTD interface in a groove positioned at the four-helix bundle (helix 21, 22 ) (Figure 1-yellow) . Site-2 is adjacent to Site-1 and represents a sub-pocket positioned at the M-domain:CTD interface of each protomer (Figure S1 -2A & 2B). Each sub-pocket is formed by residues belonging to helix18, ß-sheet [17] [18] , and helix 22 , as well as several residues located at the M-domain:CTD hinge region.
Molecular docking was utilized to separately screen a library of 702 South African natural compounds against Site-1 and Site-2. The known CTD inhibitor Novobiocin was included in both screens as a control. Due to computational constraints, the protein receptor was kept rigid and the ligands allowed flexibility around available rotatable bonds. Each compound was re-docked 100 times to ensure conformational diversity and the results filtered and analysed in terms of conformation cluster size and average estimated free energy of binding. Table 1 provides a summary of the best docked compounds for each site. . This observed binding site and orientation is in agreement with previous reports for Novobiocin 44 . Both SANC491 and SANC518 recorded lower binding free energy scores (<-11.0 kcal/mol) compared to Novobiocin (-8.97 kcal/mol) suggesting higher binding affinities. Looking at Site-2, only 3'-Bromorubrolide F (SANC309) was able to dock to the small sub-pocket in protomer B with a high degree of reproducibility and suitable binding free energy scores (-9.13 kal/mol) (Figure 1 -red). To fully examine the stability of ligand binding and to gain further insights as to the allosteric effect of each ligand, all-atom MD simulations were carried out on the protein-ligand complexes for a total 200 ns. In each case, the ligand conformation with the lowest binding free energy score from the largest cluster was selected as a representative start structure. 
Characterization of protein-ligand interactions
Ligand binding stability was assessed by monitoring the residue contribution to protein-ligand interactions over time. Hydrophobic and hydrogen bond interactions were evaluated every n th frame in the trajectory using a 200 ps time interval, and the cumulative data represented as interaction heat maps (Figure 3) . Starting with binding Site-1, Novobiocin, SANC491, and SANC518 primarily interact with residues (residues L672-Q682) from both protomers that line a distinct binding groove located at four-helix bundle of the CTD inter-protomer dimerization interface (Figure 3 -yellow).
Of these residues, L627, S677, L678, and P681 are the most consistent contributors to ligand interactions. In addition to stable hydrophobic (residues L627 and P681) and hydrogen bond interactions (residues S677 and L678), the terminal moieties of the Site-1 ligands also interact with residues (T495-F507) that line the entrance to the sub-pocket binding site in protomer B (Site-2) ( In protomer B, residues Q501, T545 and K546 form stable hydrophobic interactions with SANC309 while interactions with the remaining sub-pocket residues appear to be more transient (Figure 3 blue). The protein-ligand interaction landscape observed for SANC309 is to the best of our knowledge novel to the current study and notably overlaps with several allosteric hotspot residues (T495, E497, T545, and K546) that have been previously implicated in selecting conformational displacements in favour of the closed conformation when externally perturbed 37 .
Overall, MD simulations revealed stable protein-ligand complexes over 200 ns, and the interaction profiles for both Site-1 and Site-2 overlap with known allosteric sites opening the possibility for external modulation of Hsp90α conformational dynamics through ligand binding interactions. We investigate this possibility by monitoring the effect each ligand has on the global and internal dynamics of the protein compared to a ligand-free system and assess the respective allosteric potential of Site-1 and Site-2. Taken collectively, the results demonstrate evidence of selective ligand modulation of both whole protein mobility and domain specific flexibility depending on the identity of the bound ligand.
Conformational flexibility and rigid body mobility form the basis of enzymatic catalysis and allosteric modulation 46 and in the case of Hsp90, conformational plasticity is crucial for molecular functionality 5, 45 . The increased flexibility experienced by SANC309, especially in the M-domain where co-chaperones bind, may enable the protein to overcome energetic limitations allowing it to explore a larger conformational space, thus aiding its search for the closed catalytically active state.
Conversely, reduced protomer flexibility in SANC491 may lead to protomer elongation and a more rigid structure that favours the open conformation.
Ligand modulation of residue interaction networks
Dynamic residue networks (DRNs) 47 Starting with ΔL i (Figure 6B) , it is evident that ligand binding leads to an increase in L i , particularly at the NTDs of both protomers (~1 unit), with the largest increase observed for residues belonging to ATP-lid (residues 130-160). This observation is notably accentuated in protomer B of the SANC309 complex, with ΔL i values >3.0. It has been previously shown that ΔL i can be influenced in one of two ways: (i) a significant spatial alteration in the local neighbourhood surrounding i can affect the contribution of first and second neighbours to the average number of steps taken 37, 54 (Figure 6A) .
While the NTD and M-domain record elevated ΔL i , the CTDs experience a ~1 unit decrease in L i in both protomers. This observation is particularly apparent for residues 550-620 belonging to helix 17 and helix 18 , as well as the terminal four-helix bundle (residues 660-720). Interestingly, the former have been previously implicated as sensors to physical perturbations elsewhere in the protein 37 and implicated in signal propagation 33 . Here, scenario (i) provides a suitable explanation in that ligand binding at the CTD stabilizes the domain reducing residue fluctuations thus allowing for stable residue-residue interactions. As with L i , ΔBC is also averaged over time and comparison of the different ligand bound complexes reveals a high degree of overlap between the ligand binding sites and regions of the protein that experience large shifts in BC (Figure S4) , demonstrating the metric's sensitivity to putative ligand binding sites. Interestingly, all four ligand complexes experience increased BC at the four-helix bundle in protomer A, but a decrease in protomer B. Furthermore, it is evident that the ligand interactions between SANC491 and helix 18 (red) in protomer A has a direct impact on BC at this location possibly due to ligand stabilisation of this inherently flexible region as demonstrated by the differential ΔL i values (Figure 6) . Indeed, this finding is in agreement with our previous study in which we report an inverse relationship between BC and L i decoupled from the M-domain and CTD as indicated by the red blocks. This decoupling is particularly apparent for SANC518 and resonates with our findings in the previous inter-domain contact analysis (Figure 7) . In protomer B, the opposite effect is observed as indicated by the large blue blocks in which the NTD experiences more efficient CP between the M-domain and CTD, however this observation is less apparent for SANC518 which experiences some inter-domain decoupling in protomer B. Looking at the inter-protomer coordination patterns for these complexes, We next investigate the relative contribution of individual residues to long range coordination with distant residues elsewhere in the protein. The average CP for neighbouring residues (i ± 4) for the ligand-free complex is 0.85, and we set CP=0.85 as a suitable threshold for discriminating fast communication between residues positioned >80 Å from one another in a similar manner described by Morra and co-workers 33 . By sequentially scanning the protein we record the fraction of residues in the whole protein capable of communicating with a CP ≤ 0.85 (Figure 9) . Looking at the ligandfree complex it is evident that long range communication is established between the NTDs (residues 80-90, 150-160, 170-185) and CTDs (residues 555-580, 640-655, and 690-700) providing further evidence of NTD-CTD allosteric coupling in agreement with previous reports for yeast Hsp90 in the closed state 33 . For the ligand bound complexes, it is evident that none of the binding site residues directly contribute to long range residue communication (Figure 9 -shaded 
Essential dynamics analysis
Given the tremendous size of Hsp90 (1400 residues), our 200 ns MD trajectories are of an insufficient length to access functional global motions such as the full closing motion expected for the ATP-only complex. To circumvent this, essential dynamics (ED) analysis techniques were employed to assess whether ligand binding corresponds to functional global correlated motions. In ED, MD trajectory is represented as the covariance matrix which is used to calculate eigenvectors and eigenvalues. The former metric represents the correlated displacement of atom groups through essential space, while the latter gives an indication of the magnitude (nm 2 ). The configurational space represented by eigenvectors can be separated into two subspaces 56 ; (i) the essential subspace which represents correlated motions comprising very few degrees of freedom, which likely point to functionally relevant global motions; and (ii) the independent subspace which is constrained to local regions and offer little functional importance. Here, we focus on the former subspace (i) which is often accounted for by the first few low-frequency modes with large corresponding eigenvalues.
Analysis of the cumulative squared overlap for the first 20 modes for each complex (Figure S5) ,
shows that between 60 % and 80 % of all protein motion is accounted for by the first three eigenvectors. In each case the first two eigenvectors account for more than 50 % of all protein fluctuations, suggesting these modes represent functionally relevant protein motions. Here, we illustrate the global correlated motions associated with the first eigenvector for each complex by projecting the corresponding trajectory onto the eigenvector and interpolating over the two most extreme projections and use arrows to describe the relative atomic displacements (Figure 10,   Figure S6 and Movie S1-S5).
Figure 10:
Top down view illustration of the essential dynamics displacements for the first eigenvector of each Hsp90 complex. The Hsp90 complex is represented by C α atoms (grey spheres) and the arrows describe the relative direction and magnitude of the atomic displacements for protomer A (blue) and protomer B (red). Displacement arrows drawn for every 2 nd C α atom to simplify presentation.
In the ligand-free state, ED analysis reveals linear atomic displacements for each protomer in the opposite direction towards one other, and closely resembles the closing transition, that is expected under these conditions, in which ATP binding triggers conformational rearrangements towards the catalytically active closed state. Addition of Novobiocin gives protomer displacements in opposite directions in an opening like motion. These displacements may provide early evidence of protomer uncoupling as Novobiocin is known to disrupt protomer dimerization at the CTD 32 . Interestingly, SANC491 and SANC518 demonstrate similar linear protomer displacements to Novobiocin, providing further evidence that these compounds may invoke a similar inhibitory allosteric mechanism. SANC309 on the other hand appears to enhance protomer displacements towards each other in a similar manner to the ATP-only complex. This observation coupled with larger displacements than the ligand-free complex, may suggest SANC309 to be an allosteric activator of human Hsp90α, by promoting allosteric closure of the dimer. Indeed, this observation agrees with earlier results in which SANC309 populated conformations with smaller inter-protomer distances (Figure 4-red) . Furthermore, we note similar results for the second eigenvectors which describe rotational twisting of the protomers along their central axis in either a clockwise closing or an anticlockwise opening motions much like the twisting and untwisting of a double stranded helix.
Conclusions
Overall as is the case for Novobiocin 32 , or by allosterically enhancing the energetic barrier that must be overcome in order to access the ATPase active state 23 . Finally, we note that Cephalostatin 17 (SANC491) is known to be a potent anti-cancer agent 57,58 although its mechanism of action remains unclear. In contrast, SANC309 at Site-2 greatly enhanced protein flexibility and decreased internal coordination, characteristics that may enable the protein to overcome the energetic requirements necessary to access the closed state and therefore act as an allosteric activator. Indeed, the correlated atomic displacements observed for this complex are in agreement with our previous PRS study, in which external force perturbations at Site-2 resulted in global protein displacements towards the closed catalytic conformation 37 , providing proof of concept for this approach through simulated ligand interactions. In summary, our findings provide novel insights regarding the selective external modulation of Hsp90α conformational dynamics, and shed valuable insight on allosteric drug development for Hsp90 as well as the protein's complex allosteric mechanism of action. Additionally, this is the first study that applies combined information from PRS coupled with DRN to identify potential allosteric sites for inhibitor design. This proposed approach should be applicable in identifying allosteric drug targeting sites in other proteins.
Methodology
Molecular docking
The 
Molecular dynamics
All MD simulations were performed using GROMACS 5.1.2 62, 63 with in the CHARMM 36 force field [64] [65] [66] , using a orthorhombic periodic box with a clearance space of 1.5 nm. Water molecules were added as solvent, and modeled with the TIP3P water model, and the system neutralized using a 0.15 M NaCl concentration. Prior to production runs, each system was first energy minimized using a conjugate-gradient and energy relaxed up to 50 000 steps of steepest-descent energy minimization, and terminated when the maximum force < 1000.0 kJ/mol/nm. Energy minimization was followed by equilibration, first in the NVT ensemble at 310 K using Berendsen temperature coupling, and then in the NPT ensemble at 1 atm and 310 K until the desired average pressure (1 atm) was maintained and volumetric fluctuations stabilized. All production simulations were run for a minimum of 200 ns, and the backbone root-mean-square deviation (RMSD) of the protein monitored for convergence. Coordinate data for the protein and ligand were saved at 2 ps intervals for further analysis. All simulations utilized the LINCS algorithm for bond length constraints and the fast particle mesh Ewald method was used for long-range electrostatic forces. The switching function for van der Waals interactions was set to 1.0 nm and the cutoff to 1.2 nm. NH3 + and COO − groups were used to achieve the zwitterionic form of the protein and periodic boundary conditions were applied in all directions and the simulation time step set to 2 fs. All trajectory clustering analyses were carried out with the GROMACS 5 cluster function using the gromos method described by Daura and co-workers 59 using a cutoff of 0.2 nm. The RMSD values for each complex are displayed in Figure S2 .
Protein-ligand interactions
The Protein Ligand Interaction Profiler (PLIP) 17 
Dynamic residue networks
To analyse inter-and intra-domain communication, the protein is represented as a residue interaction network (RIN), where the C β atoms of each residue (C α for glycine) are treated as nodes within the network, and edges between nodes defined within a distance cut off of 6.7 Å 67 . In this manner, the RIN was constructed as a symmetric N × N matrix, where the ij th element is assigned as 1 if residue i is connected to residue j and a zero if no connection exists.
In this study, MD-TASK 47 was used to construct dynamic residue networks (DRN) for each MD trajectory, in which RINs are constructed for every n th frame of the trajectory using a 200 ps time interval, to build a DRN matrix. By iterating over the DRN, each RIN is analysed in terms of the average of shortest path length (L ij ) between residue i and any other residue j, and betweenness centrality (BC) of each residue. The shortest path length between two residues i and j is defined as being the number of nodes that need to be crossed to reach j from i. The average L ij is then calculated as the average number of steps that the node/residue may be reached from all other residues in the RIN:
Here, we analyse the change in reachability (ΔL i ) of each residue by monitoring how L i shifts over the course of the MD trajectory:
where 0 denotes the average shortest path length for residue i at time zero, and the average shortest path length at frame n BC is defined as the number of shortest paths running through a node/residue for a given RIN, and provides a measure of usage frequency each node during navigation of the network. Here, BC was calculated using MD-TASK based on Dijkstra's algorithm 68 Inter-domain contacts between the NTD and M-domain were evaluated using contact_map.py script from MD-TASK with a distance cut-off of 6.7 Å. The script was utilized every 200 ps and the resultant data collated into a single data frame for plotting purposes.
Communication propensity
The pairwise communication propensity (CP) describes the efficiency of communication between residues i and j and is based on the notion that signal transduction events in proteins are directly related to the distance fluctuation of the communicating atoms 33, 55 . CP is thus defined as a function of the inter-residue distance fluctuations, where residues whose Cα -Cα distance fluctuates with low intensity are thought to communicate more efficiently (faster) compared to residues whose distance fluctuations are large in which the amplitude of the fluctuations results in slower inter-residue communication. CP is calculated as the mean-square fluctuation of the inter-residue distance = 〈� − , � 2 〉 where d ij is the time dependent distance between the Cα atoms of residues i and j respectively, and the brackets denote the time-average over the trajectory. In this study, the resultant CP matrix is used to assess the relative impact each compound has on the internal dynamics and overall flexibility of the protein, by calculating the difference matrix between each ligand bound complex
to the ligand-free (ATP only) complex.
Principal component analysis
Principal completed analysis (PCA) was used for the analysis of global motions present over the course of each MD simulation 56 . This technique involves two main steps: 1) the construction the covariance matrix, C, based on the positional deviation of each Cα atom, and 2) dimensionality (4)
Supporting information
Figure S1: FTMap unbiased screen reveals two putative ligand binding sites in the CTD. Site-1 is located at the four-helix bundle. Site-2 is mirrored in both protomers Site-2A and 2B respectively. The Hsp90 complex is represented by C α atoms (grey spheres) and the arrows describe the relative direction and magnitude of the atomic displacements for protomer A (blue) and protomer B (red). Displacement arrows drawn for every 2 nd C α atom to simplify presentation.
Movie S1: Correlated motions for the ligand-free complex: Depicting dimer closure as protomer A (green) approaches protomer B (cyan).
Movie S2: Correlated motions for the Novobiocin complex:
Depicting dimer opening as protomer A (green) and protomer B (cyan) displace in opposite directions.
Movie S3: Correlated motions for the SANC309 complex: Depicting dimer closure as protomer A (green) approaches protomer B (cyan).
Movie S4: Correlated motions for the SANC491complex: Depicting dimer opening as protomer A (green) and protomer B (cyan) displace in opposite direction.
Movie S5: Correlated motions for the SANC518 complex: Depicting dimer opening as protomer A (green) and protomer B (cyan) displace in opposite directions.
